Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Poikonen, Eira ^a   Lyytikäinen, Outi ^b   Anttila, Veli Jukka ^c   Koivula, Irma ^d   Lumio, Jukka ^e   Kotilainen, Pirkko ^f   Syrjälä, Hannu ^g   Ruutu, Petri ^b  

^a PEIJAS HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

^g OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDEMIA; CHILD; CONTROLLED STUDY; DRUG USE; FEMALE; FINLAND; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; LABORATORY TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREMATURITY; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; TELECONSULTATION; TERTIARY HEALTH CARE; TREND STUDY; CANDIDA; CANDIDIASIS; CHEMOPROPHYLAXIS; CLASSIFICATION; DRUG UTILIZATION; FUNGEMIA; INTERVIEW; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; NEWBORN; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; FINLAND; FLUCONAZOLE; FUNGEMIA; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77958585627     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-312     Document Type: Article

References (38)

1. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003, 37(9):1172-7. 10.1086/378745, 14557960.
2. Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005, 26(6):540-7. 10.1086/502581, 16018429.
3. Olaechea PM, Palomar M, Leon-Gil C, et al. Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004, 23(4):323-30. 10.1007/s10096-004-1104-x, 15024623.
4. Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998, 27(4):781-8. 10.1086/514955, 9798034.
5. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005, 41(9):1232-9. 10.1086/496922, 16206095.
6. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999, 29(2):239-44. 10.1086/520192, 10476719.
7. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagn Microbiol Infect Dis 1998, 30(2):121-9. 10.1016/S0732-8893(97)00192-2, 9554180.
8. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39(3):309-17. 10.1086/421946, 15306996.
9. Lyytikainen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P. Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 2002, 35(2):e14-9. 10.1086/340981, 12087538.
10. Voss A, Kluytmans JA, Koeleman JG, et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996, 15(12):909-12. 10.1007/BF01690507, 9031872.
11. Bouza E, Perez-Molina J, Munoz P. Cooperative Group of the European Study Group on Nosocomial Infections (ESGNI). Report of ESGNI-001 and ESGNI-002 studies. Bloodstream infections in Europe. Clin Microbiol Infect 1999, 5(Supplement 2):2S1-2S12.
12. Diekema DJ, Messer SA, Brueggemann AB, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002, 40(4):1298-302. 10.1128/JCM.40.4.1298-1302.2002, 140380, 11923348.
13. Hajjeh RA, Sofair AN, Harrison LH, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004, 42(4):1519-27. 10.1128/JCM.42.4.1519-1527.2004, 387610, 15070998.
14. Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999, 29(5):1164-70. 10.1086/313450, 10524958.
15. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis 1998, 27(5):1138-47. 10.1086/514975, 9827260.
16. Arendrup MC, Fuursted K, Gahrn-Hansen B, et al. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect 2008, 14(5):487-94. 10.1111/j.1469-0691.2008.01954.x, 18294241.
17. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 2002, 40(9):3489-92. 10.1128/JCM.40.9.3489-3492.2002, 130691, 12202600.
18. Asmundsdottir LR, Erlendsdottir H, Haraldsson G, Guo H, Xu J, Gottfredsson M. Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis 2008, 47(2):e17-24. 10.1086/589298, 18549311.
19. Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsaker T, Gaustad P. Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol 2006, 44(6):1977-81. 10.1128/JCM.00029-06, 1489391, 16757587.
20. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997, 24(6):1122-8. 10.1086/513663, 9195068.
21. Chen S, Slavin M, Nguyen Q, et al. Active surveillance for candidemia, Australia. Emerg Infect Dis 2006, 12(10):1508-16.
22. Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009, 48(12):1695-703. 10.1086/599039, 19441981.
23. Nguyen MH, Peacock JE, Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996, 100(6):617-23. 10.1016/S0002-9343(95)00010-0, 8678081.
24. Pfaller MA, Diekema DJ. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 2004, 10(Suppl 1):11-23. 10.1111/j.1470-9465.2004.t01-1-00844.x, 14748799.
25. San Miguel LG, Cobo J, Otheo E, Sanchez-Sousa A, Abraira V, Moreno S. Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis. Infect Control Hosp Epidemiol 2005, 26(6):548-52. 10.1086/502582, 16018430.
26. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002, 35(5):627-30. 10.1086/342300, 12173140.
27. Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002, 21(11):767-74. 10.1007/s10096-002-0822-1, 12461585.
28. Tortorano AM, Biraghi E, Astolfi A, et al. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 2002, 51(4):297-304. 10.1053/jhin.2002.1261, 12183145.
29. Poikonen E, Lyytikainen O, Anttila VJ, Ruutu P. Candidemia in Finland, 1995-1999. Emerg Infect Dis 2003, 9(8):985-90.
30. Laupland KB, Gregson DB, Church DL, Ross T, Elsayed S. Invasive Candida species infections: a 5 year population-based assessment. J Antimicrob Chemother 2005, 56(3):532-7. 10.1093/jac/dki258, 16040623.
31. Almirante B, Rodriguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005, 43(4):1829-35. 10.1128/JCM.43.4.1829-1835.2005, 1081396, 15815004.
32. Sarvikivi E, Lyytikainen O, Soll DR, et al. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol 2005, 43(6):2729-35. 10.1128/JCM.43.6.2729-2735.2005, 1151957, 15956390.
33. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect 2002, 50(1):56-65. 10.1053/jhin.2001.1131, 11825053.
34. Blot S, Janssens R, Claeys G, et al. Effect of fluconazole consumption on long-term trends in candidal ecology. J Antimicrob Chemother 2006, 58(2):474-7. 10.1093/jac/dkl241, 16757503.
35. Lagrou K, Verhaegen J, Peetermans WE, De Rijdt T, Maertens J, Van Wijngaerden E. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis 2007, 26(8):541-7. 10.1007/s10096-007-0339-8, 17569999.
36. Marchetti O, Bille J, Fluckiger U, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004, 38(3):311-20. 10.1086/380637, 14727199.
37. Poikonen E, Lyytikainen O, Anttila VJ, et al. Nosocomial candidaemia in a Finnish tertiary care centre during 1987-2004. Scand J Infect Dis 2009, 1:1-7.
38. Berrouane YF, Herwaldt LA, Pfaller MA. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol 1999, 37(3):531-7. 84452, 9986807.